SGLT2 inhibitors and thiazide enhance excretion of DEHP toxic metabolites in subjects with type 2 diabetes: a randomized clinical trial.

[1]  A. Scheen.  Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus , 2020, Nature Reviews Endocrinology.

[2]  C. Hsiung,et al.  The sex-specific association of phthalate exposure with DNA methylation and characteristics of body fat in children. , 2020, The Science of the total environment.

[3]  F. Maranghi,et al.  Biomonitoring of Bis(2-ethylhexyl)phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project. , 2020, Environmental research.

[4]  6. Glycemic Targets: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[5]  T. Brüning,et al.  Metabolism and urinary excretion kinetics of di(2-ethylhexyl) adipate (DEHA) in four human volunteers after a single oral dose. , 2019, Toxicology letters.

[6]  R. Rapoport,et al.  Mechanism of Thiazide Diuretic Arterial Pressure Reduction: The Search Continues , 2019, Front. Pharmacol..

[7]  M. Kamijima,et al.  Di(2-ethylhexyl) phthalate-induced toxicity and peroxisome proliferator-activated receptor alpha: a review , 2019, Environmental Health and Preventive Medicine.

[8]  M. Du,et al.  Use of dietary supplements in relation to urinary phthalate metabolite concentrations: Results from the National Health and Nutrition Examination Survey. , 2019, Environmental research.

[9]  C. Maia,et al.  Effects of di(2-etilhexil) phthalate on human umbilical artery. , 2019, Chemosphere.

[10]  K. Kannan,et al.  A Review of Biomonitoring of Phthalate Exposures , 2019, Toxics.

[11]  Ho-Shik Kim,et al.  Empagliflozin Contributes to Polyuria via Regulation of Sodium Transporters and Water Channels in Diabetic Rat Kidneys , 2019, Front. Physiol..

[12]  Risk assessment of phthalates in pharmaceuticals , 2019, Journal of toxicology and environmental health. Part A.

[13]  A. Mengozzi,et al.  Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional Study. , 2018, The Journal of clinical endocrinology and metabolism.

[14]  N. Skakkebaek,et al.  Changes in urinary excretion of phthalates, phthalate substitutes, bisphenols and other polychlorinated and phenolic substances in young Danish men; 2009-2017. , 2019, International journal of hygiene and environmental health.

[15]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[16]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)]. , 2018, Giornale italiano di cardiologia.

[17]  T. Göen,et al.  Human metabolism and kinetics of tri-(2-ethylhexyl) trimellitate (TEHTM) after oral administration , 2018, Archives of Toxicology.

[18]  T. Ahern,et al.  Cumulative exposure to phthalates from phthalate‐containing drug products: a Danish population‐wide study , 2018, British journal of clinical pharmacology.

[19]  A. Neugut,et al.  Urinary Phthalate Metabolite Concentrations and Breast Cancer Incidence and Survival following Breast Cancer: The Long Island Breast Cancer Study Project , 2018, Environmental health perspectives.

[20]  R. Dales,et al.  The associations between phthalate exposure and insulin resistance, β-cell function and blood glucose control in a population-based sample. , 2018, The Science of the total environment.

[21]  E. Tsai,et al.  The Impact of Di(2-ethylhexyl)phthalate on Cancer Progression , 2018, Archivum Immunologiae et Therapiae Experimentalis.

[22]  Robin E. Dodson,et al.  Reducing chemical exposures at home: opportunities for action , 2017, Journal of Epidemiology & Community Health.

[23]  Bo Chen,et al.  Sex Differences in the Association of Urinary Concentrations of Phthalates Metabolites with Self-Reported Diabetes and Cardiovascular Diseases in Shanghai Adults , 2017, International journal of environmental research and public health.

[24]  Mohamed H. Shahin,et al.  Mechanisms and pharmacogenetic signals underlying thiazide diuretics blood pressure response. , 2016, Current opinion in pharmacology.

[25]  J. Meeker,et al.  Exposure assessment issues in epidemiology studies of phthalates. , 2015, Environment international.

[26]  Oa.  America's Children and the Environment (ACE) , 2015 .

[27]  P. Rudnai,et al.  First Steps toward Harmonized Human Biomonitoring in Europe: Demonstration Project to Perform Human Biomonitoring on a European Scale , 2014, Environmental Health Perspectives.

[28]  Yan Zhao,et al.  Age and Sex-Specific Relationships between Phthalate Exposures and Obesity in Chinese Children at Puberty , 2014, PloS one.

[29]  A. Alshawabkeh,et al.  Urinary Phthalate Metabolite Associations with Biomarkers of Inflammation and Oxidative Stress Across Pregnancy in Puerto Rico , 2014, Environmental science & technology.

[30]  T. Brüning,et al.  Identifying sources of phthalate exposure with human biomonitoring: results of a 48h fasting study with urine collection and personal activity patterns. , 2013, International journal of hygiene and environmental health.

[31]  S. Genuis,et al.  Human Elimination of Phthalate Compounds: Blood, Urine, and Sweat (BUS) Study , 2012, TheScientificWorldJournal.

[32]  L. Lind,et al.  Circulating Levels of Phthalate Metabolites Are Associated With Prevalent Diabetes in the Elderly , 2012, Diabetes Care.

[33]  S. Hernández-Díaz,et al.  Identification of Phthalates in Medications and Dietary Supplement Formulations in the United States and Canada , 2011, Environmental health perspectives.

[34]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[35]  Antonia M. Calafat,et al.  Temporal Variability of Urinary Phthalate Metabolite Levels in Men of Reproductive Age , 2004, Environmental health perspectives.

[36]  A. Calafat,et al.  Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. , 2004, Environmental health perspectives.

[37]  Holger M. Koch,et al.  Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP , 2004, Archives of Toxicology.